Reversing Cognitive Decline: Groundbreaking Results from a Randomized Controlled Trial of Precision Medicine in Alzheimer’s Disease

19 Jun 2026
Level 5 - Mountbatten Room

This presentation will discuss the exciting results from our randomized controlled trial using a personalized, multimodal precision medicine approach to reverse mild cognitive impairment and early Alzheimer's.   The session will provide a practical roadmap for physicians seeking to move beyond monotherapeutic models and implement precision brain health strategies within their own practices.

Speakers
Kat Toups
Dr Kat Toups, MD, DFAPA, IFMCP & Lead Investigator - Evanthea Dementia Reversal Trial USA